- Home
- SLP vs IRMD Comparison
SLP vs IRMD Comparison
Compare SLP & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLP
- IRMD
- Stock Information
- Founded
- SLP 1996
- IRMD 1992
- Country
- SLP United States
- IRMD United States
- Employees
- SLP N/A
- IRMD N/A
- Industry
- SLP EDP Services
- IRMD Medical/Dental Instruments
- Sector
- SLP Technology
- IRMD Health Care
- Exchange
- SLP Nasdaq
- IRMD Nasdaq
- Market Cap
- SLP 675.9M
- IRMD 668.2M
- IPO Year
- SLP 1997
- IRMD 2014
- Fundamental
- Price
- SLP $26.37
- IRMD $57.79
- Analyst Decision
- SLP Buy
- IRMD Strong Buy
- Analyst Count
- SLP 8
- IRMD 1
- Target Price
- SLP $47.83
- IRMD $72.00
- AVG Volume (30 Days)
- SLP 296.7K
- IRMD 36.2K
- Earning Date
- SLP 07-01-2025
- IRMD 07-31-2025
- Dividend Yield
- SLP 0.23%
- IRMD 1.17%
- EPS Growth
- SLP N/A
- IRMD 10.72
- EPS
- SLP 0.36
- IRMD 1.55
- Revenue
- SLP $78,564,000.00
- IRMD $75,154,639.00
- Revenue This Year
- SLP $30.21
- IRMD $10.62
- Revenue Next Year
- SLP $11.83
- IRMD $9.69
- P/E Ratio
- SLP $73.23
- IRMD $37.46
- Revenue Growth
- SLP 21.49
- IRMD 11.04
- 52 Week Low
- SLP $23.01
- IRMD $41.69
- 52 Week High
- SLP $50.11
- IRMD $63.29
- Technical
- Relative Strength Index (RSI)
- SLP 31.23
- IRMD 64.35
- Support Level
- SLP $31.79
- IRMD $50.88
- Resistance Level
- SLP $34.01
- IRMD $59.05
- Average True Range (ATR)
- SLP 1.64
- IRMD 1.93
- MACD
- SLP -0.40
- IRMD 0.57
- Stochastic Oscillator
- SLP 0.78
- IRMD 84.58
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.